Skip to content
Search

Latest Stories

COVID-19 backlog not likely to be cleared by 2025, even with 30% capacity boost

COVID-19 backlog not likely to be cleared by 2025, even with 30% capacity boost
Photo: iStock

Experts underscore the need to improve healthcare system resilience to reduce the effects of any future emergencies   

NHS England will not be able to clear the COVID-19 backlog before the end of 2025 even if the system capacity is increased by 30 per cent compared to pre-pandemic levels, according to a new study published in the Lancet.


Researchers from the Universities of Edinburgh and Strathclyde evaluated the impact of the pandemic on NHS waiting times for elective hospital care.

At the end of October 2022, there were more than 7.2 million patient referrals waiting for treatment in England, an increase of 2·6 million from February 2020, when the total pending referrals was 4·6 million.

In January 2012, the number of pending referrals was 2·4 million, and the list increased by about 2·2 million in the eight years before the pandemic between January 2012 and February 2020.

The statistics indicate that the service was already struggling to keep up with the demand many years before the pandemic, and the disease outbreak only aggravated the problem, said Dr Syed Ahmar Shah from the University of Edinburgh’s Usher Institute, who led the study.

However, the experts assumed that the true backlog could be much higher, as large numbers of patients have still not come forward for care.

Their models estimated more than 10 million missing referrals from the beginning of the COVID-19 pandemic to Oct 31, 2022.

NHS England's COVID recovery plan aims to deliver around 30 per cent more elective activity by 2024/25 than before the pandemic, through a range of measures, including extra staff and increased use of the independent sector.

Even with this much increase in system capacity, several years would be needed to clear the backlog, the researchers said.

They suggested that the system capacity should be increased by more than 10 per cent to reverse the increasing trend in waiting lists.

The experts underscored the need to improve health-care system resilience to minimise the effects of any future emergencies on the provision of routine care.

“Moving ahead, it is evident that we cannot afford to leave our healthcare systems strained; instead, we must enhance their resilience to ensure better preparedness for any future emergencies,” Dr Shah added.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less